September 11, 2025
Merck scraps plans for £1 billion London research centre in blow to life sciences sector
US pharmaceutical company Merck, known as MSD in Europe, has withdrawn a planned £1 billion investment in a new discovery centre in London, citing the UK’s challenging environment for life sciences. The decision will result in the closure of discovery research operations in the country and the loss of 125 jobs, although other research activities will continue. The facility, a 25,000 square foot headquarters in the Knowledge Quarter near King’s Cross, had been under construction and was due to open in 2027. The cancellation comes at a time when the government has identified life sciences as a key growth sector in its industrial strategy, with ambitions to make the UK Europe’s leading life sciences economy by 2030 and the third most significant globally by 2035. More →